Articles Posted in Mass Torts

Our lawyers represent victims seeking a Camp Lejeune lawsuit in all 50 states.

This page provides more comprehensive and updated information on Camp Lejeune claims:

Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases.  We also recently reopened the comments below to answer any questions you may have or just give you a chance to say what is on your mind.

This page is about the AFFF lawsuits and where we are as we approach 2025.

Victims have been waiting a long time, hoping for firefighting foam settlement. Is there a settlement on the horizon? If compensation payouts are offered, what could they be?

In the summer of 2023, many AFFF water contamination claims filed by local water authorities and municipalities were resolved in a global settlement agreement. 3M, DuPont, and the other defendants will reportedly pay $10.3 billion to resolve these claims as part of the settlement deal.

The promise of Leqembi and Kisunla—drugs that aim not just to ease symptoms but to slow Alzheimer’s disease—was compelling. Alzheimer’s is an awful disease. But as reports emerge of serious brain injuries among clinical trial participants, including bleeding and swelling. Victims who have suffered injuries in these clinical trials may have potential lawsuits for injuries because they were not fully informed of their potential genetic risks before enrolling.

This is very new litigation.  This page explains how potential Leqembia and Kisunla lawsuits might work and what they would involve.  If you have a potential brain bleed or brain injury lawsuit, call us today at 800-553-8082 or get a free consultation online.

Alzheimer’s Treatments with a Double-Edged Sword

The Cartiva toe implant is a synthetic cartilage device used to treat arthritis in the big toe. New evidence suggests that these implants are defectively designed and prone to failures that can result in pain, further surgery, and other injuries. Cartiva toe implant lawsuits are now being filed by individuals who experienced a premature failure of their implant.

We hoped to see Cartiva settlement payouts by 2024 from a global settlement. That has not happened. Unfortunately, this litigation is dragging on. But these lawsuits could reach a settlement at any time. You want to submit a case before that happens. So, if you have a claim, call us or another lawyer sooner rather than later.

Not many of these lawsuits have been filed. The last Cartiva lawsuit we saw was on June 28, 2024, in West Virginia. But there are a lot more cases out there, and that is likely to change if there is not a settlement soon. If you have a potential claim, call us today at 800-553-8082 or get a free consultation online.

Our lawyers are handling Paragard IUD removal lawsuits in all 50 states. These lawsuits allege the Paragard intrauterine device breaks upon removal because it is made with inflexible plastic and degrades before the device expires. Over 2,500 lawsuits have been lodged against Teva Pharmaceutical and CooperSurgical by women who encountered issues such as breakage during removal or implantation or other complications associated with the Paragard birth control device.

This page provides an update on the Paragard class action lawsuit and speculates on the Paragard settlement amounts.

You can reach our lawyers at 800-553-8082 or get a free online consultation. You pay nothing unless you get a recovery for the injuries related to your Paragard breaking during removal.

Our lawyers can help you bring a Valsartan cancer lawsuit in all 50 states.

Valsartan is a popular blood-pressure drug used by millions of people in the U.S. and sold under the brand names Diofan and Exforge. But Valsartan was recalled after it was discovered that the drug was contaminated with dangerously high levels of a carcinogenic chemical called NDMA. Continue reading

The Bard PowerPort (“BardPort”) is a port catheter device implanted just under the skin to allow for easy attachment to a catheter for the intravenous delivery of fluids or medication.

The Bard PowerPort has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position. This can cause severe injuries, including internal vascular damage.

Individuals who suffered injuries due to a defective Bard PowerPort device are now bringing product liability lawsuits against the manufacturer of the PowerPort implants. Our firm is currently accepting new cases from anyone who had a Bard PowerPort port catheter device implanted and was injured due to a fracture, migration, or other implant failures.

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas.  Our law firm is reviewing NEC lawsuits in all 50 states.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis.  These newborn NEC formula lawsuits make a lot of allegations.  But at their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families and give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to participate in a class action lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.

Our lawyers are handling baby powder lawsuits in all 50 states. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides a J&J talc power litigation update and discusses what the settlement amounts in these ovarian cancer lawsuits will be for victims.

Below are the latest talc powder lawsuit news updates and information on how to bring a claim in 2024.

Contact Information